Dr. Yessayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2850 South Industrial Hwy
Ann Arbor, MI 48104Phone+1 734-677-1490
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2003 - 2006
American University of Beirut Faculty of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2003 - 2025- American Board of Internal Medicine Nephrology
Clinical Trials
- Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients Start of enrollment: 2019 Sep 24
Publications & Presentations
PubMed
- Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions.Sai Prasad N Iyer, Christopher J Pino, Lenar T Yessayan, Stuart L Goldstein, Matthew R Weir
Transplantation Direct. 2024-06-01 - Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical Comparator.Stuart L Goldstein, Nicholas J Ollberding, David J Askenazi, Rajit K Basu, David T Selewski
Kidney Medicine. 2024-04-01 - 1 citationsExtracorporeal Immunomodulation Therapy in Acute Chronic Liver Failure With Multiorgan Failure: First in Human Use.Lenar T Yessayan, Pratima Sharma, Angela J Westover, Balazs Szamosfalvi, H David Humes
ASAIO Journal. 2024-03-01
Press Mentions
- Exploring a New Weapon Against COVID-19 Cytokine StormNovember 3rd, 2020
- Spectral and Dialco Sponsored Symposiums at the 38th Vicenza Course on AKI and CRRTNovember 2nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
